Burning Rock Biotech Limited (BNR)

R&D Expense Growth

13.44%

Quarterly · Period ending:

BNR logo

BNR R&D Expense Growth

Latest reported13.44%
BNR Quarterly R&D Growth (QoQ) (0.00% → 13.44%)
High-resolution chart · PNG

BNR r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
13.4418%
-20.9574%
-15.9227%
-16.6787%
23.2266%
-22.6309%
6.2116%
-24.3287%
-1.5655%
-9.7567%
-12.6426%
-12.6103%
1.4425%
-6.3574%
-7.8642%
18.8043%
-22.9162%
6.0076%
61.8458%
-35.5526%
39.6014%
-7.1975%
20.3202%
-2.5936%
77.8689%
-23.3968%
36.47%
9.3907%
11.3437%
-2.7841%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.